Thu, Feb 26, 2015, 11:55 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

MannKind Corp. Message Board

  • solantey@sbcglobal.net solantey Apr 22, 2013 11:08 AM Flag

    Bottom In the $2.85 Range

    If there is no partner before the end of the year.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • jstokcton@gmail.com jstokcton Apr 22, 2013 11:23 AM Flag

      Mann will not partner until it's approved, that way he can get a huge premium. He ain't no dummy!!!
      Don't forget that this is still under $5 a share. When this creeps over (probably around May) you will see a lot of activity. The big boys will start moving around a lot. $6-$8 by Fall. This will not fall below $3.50 again.

      I'm sure there will be a warning, but that will be normal. Look at some of the side effects for most drugs out there. If you read them all, you probably would never take them.

      There is nothing else out there like this!!! This is the game changer. Not to mentions the Technosphere Technology-that's a multi-billion dollar business right there.

      Sentiment: Strong Buy

    • solantey@sbcglobal.net solantey Apr 22, 2013 11:11 AM Flag

      I don't think a "big pharma" drug company is going to enter into a partnership agreement with Mannkind prior to the next F.D.A. decision. The diminished lung capacity issue could results in a number of "REMS" requirements placed on Afrezza.

      The liability issue could be a stumbling block. I think "thestreet" has similar expectations.

 
MNKD
6.82-0.09(-1.30%)Feb 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.